12 Health Care Stocks Moving In Thursday's Intraday Session

Loading...
Loading...

Gainers

  • TG Therapeutics TGTX stock rose 57.5% to $8.13 during Thursday's regular session. Trading volume for TG Therapeutics's stock is 5.1 million as of 12:30 EST. This is 209.1% of its average full-day volume over the last 100 days. The company's market cap stands at $1.1 billion. As per the news, the Q3 earnings report came out today.
  • PetIQ PETQ shares moved upwards by 38.46% to $9.9. Trading volume for this security as of 12:30 EST is 973.5K, which is 157.2% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $290.1 million. As per the news, the Q3 earnings report came out yesterday.
  • BioLife Solns BLFS shares moved upwards by 36.53% to $23.62. As of 12:30 EST, BioLife Solns's stock is trading at a volume of 611.6K, which is 177.5% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $1.0 billion. As per the press release, Q3 earnings came out yesterday.
  • ZimVie ZIMV shares moved upwards by 31.33% to $9.64. Trading volume for this security as of 12:30 EST is 493.1K, which is 145.6% of its average full-day volume over the last 100 days. The company's market cap stands at $251.4 million. The company's, Q3 earnings came out yesterday.
  • Invitae NVTA shares moved upwards by 29.38% to $2.95. As of 12:30 EST, Invitae's stock is trading at a volume of 14.8 million, which is 81.9% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $716.5 million. As per the news, the Q3 earnings report came out 2 days ago.
  • NanoString Technologies NSTG shares increased by 26.79% to $7.43. Trading volume for NanoString Technologies's stock is 1.4 million as of 12:30 EST. This is 147.6% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $346.5 million. As per the press release, Q3 earnings came out 3 days ago.

Losers

  • Apyx Medical APYX stock declined by 62.8% to $1.64 during Thursday's regular session. Trading volume for Apyx Medical's stock is 1.8 million as of 12:30 EST. This is 1390.0% of its average full-day volume over the last 100 days. The company's market cap stands at $56.6 million. The company's, Q3 earnings came out today.
  • Brainstorm Cell BCLI shares declined by 43.26% to $1.64. As of 12:30 EST, Brainstorm Cell's stock is trading at a volume of 1.6 million, which is 685.6% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $59.8 million.
  • Cano Health CANO shares fell 32.49% to $2.25. As of 12:30 EST, Cano Health's stock is trading at a volume of 21.7 million, which is 244.0% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $544.7 million. As per the press release, Q3 earnings came out yesterday.
  • Vigil Neuroscience VIGL shares fell 22.98% to $9.49. The market value of their outstanding shares is at $268.2 million. As per the press release, Q3 earnings came out today.
  • NeuroBo Pharmaceuticals NRBO shares fell 19.79% to $1.3. Trading volume for this security as of 12:30 EST is 5.1 million, which is 299.4% of its average full-day volume over the last 100 days. The company's market cap stands at $1.1 million.
  • Organogenesis Hldgs ORGO shares declined by 19.26% to $2.5. As of 12:30 EST, Organogenesis Hldgs's stock is trading at a volume of 1.3 million, which is 140.0% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $326.5 million. As per the press release, Q3 earnings came out yesterday. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: MoversBZI-TFM
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...